National Toxicity Center dismisses safety concerns over analgesics

Published: 2009-01-12 07:00:00

Updated: 2009-01-12 07:00:00

No new safety concerns are raised by a review of adverse events reported in people taking analgesics containing isopropylantipyrine (IPA), a substance that has been linked to side effects including cardiovascular disorders, unconsciousness and spasms, according to the National Institute of Toxico...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK